about
CIN85 regulates dopamine receptor endocytosis and governs behaviour in miceThe glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytesSETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteinsSETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesionElectronic research: an opportunity for the Society for Neuro-OncologySrc phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activitiesSETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytesNuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles.Exploratory analysis of the copy number alterations in glioblastoma multiforme.Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.A simple guide screw method for intracranial xenograft studies in mice.Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cellsAccess to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIIIProteomics: the new frontier also for brain tumor research.Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.The p53 gene and its role in human brain tumors.Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons.Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies.International Hermelin Brain Tumor Center Symposium on Apoptosis.Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or divisionThe proliferation marker pKi-67 organizes the nucleolus during the cell cycle depending on Ran and cyclin BBiomarkers and cancer stem cells in primary brain tumors. Foreword
P50
Q24321812-8111DDC3-E728-4630-918D-E2F1F2E6E28CQ28138592-EF2A594B-51E7-42C9-A20E-4883BBF4F563Q28142434-4F6C5094-A31D-4033-84DB-CF4D14078174Q28207223-3CAA7BA3-6541-4AE7-9CBB-006C1CC7261EQ28757358-BADBB560-709D-4814-A034-4CADAD4EC205Q30160396-A06F678A-6C0F-4D94-8C67-BA268C39DE2DQ30168280-9F29DCDA-F0B5-4176-99B1-7D1E943964C4Q30416775-216136BF-C9D4-4E76-A57E-39A5C85FD878Q33216939-A7E6245B-FEE6-4996-9012-ED7307E24153Q33396458-5DEE2FAF-099F-4367-A64D-E806E251018DQ33779928-C3019A92-0A76-47E4-BEE8-A3A897B17778Q34581026-526FA2D3-FA69-4FB2-A213-B98C00317895Q34629812-5767B631-1717-4AB6-AD26-981E59F480C2Q35210478-9A29F4C2-2397-431B-8A20-19BB3BF04573Q35218835-3E072974-B8AC-490B-9653-B116097AA6EAQ35586066-AFF6103E-74B2-460D-9D5E-291A1053AAD6Q35591156-D91EF4B7-352F-4208-A0C5-9D2E1BBD98A1Q35631729-DE2B761B-4276-4500-B1EC-2B1BEB50962AQ35800638-EDBA4E44-F220-40CC-8C10-15F05C9BA824Q36567577-CFF126AD-3E46-4E34-B76A-74736C9B7DD3Q36579570-EB19B8F2-8C78-4EE3-93E0-1C1A9EF6F8C4Q37172551-8B96547C-A9E9-411F-ABFE-B89C164AF45FQ37527117-3B204B73-B78D-4481-BDA2-99EDD24FDDA6Q40245253-BF57DFC4-3466-4A46-8450-111B745DD770Q40961528-27D77FFA-6B1D-4F33-9FC7-C38004F7EE16Q44870612-E38AB0F3-7B7E-463C-913E-D90AA7E6AD60Q45135836-5A827454-DAEA-483E-8E27-049AC8D09513Q48219579-2A815AD0-01FC-4D6A-867E-72AECE1E3269Q72345756-BEABB96F-657A-478F-B4C0-310F90F54692Q78634763-6433E28D-E8BE-45E1-8B78-A7F90DDFE9BAQ81333007-D6B26BE1-0A1C-44F1-A8AC-12B70F64D1AC
P50
description
researcher, ORCID id # 0000-0002-3700-0480
@en
wetenschapper
@nl
name
Oliver Bogler
@ast
Oliver Bogler
@en
Oliver Bogler
@es
Oliver Bogler
@nl
type
label
Oliver Bogler
@ast
Oliver Bogler
@en
Oliver Bogler
@es
Oliver Bogler
@nl
prefLabel
Oliver Bogler
@ast
Oliver Bogler
@en
Oliver Bogler
@es
Oliver Bogler
@nl
P108
P106
P108
P1153
7003606929
P31
P496
0000-0002-3700-0480